Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers

Abstract

To identify susceptibility variants for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we conducted a genome-wide association study by genotyping 440,794 SNPs in 355 chronic HBV carriers with HCC and 360 chronic HBV carriers without HCC, all of Chinese ancestry. We identified one intronic SNP (rs17401966) in KIF1B on chromosome 1p36.22 that was highly associated with HBV-related HCC and confirmed this association in five additional independent samples, consisting of 1,962 individuals with HCC, 1,430 control subjects and 159 family trios. Across the six studies, the association with rs17401966 was highly statistically significant (joint odds ratio = 0.61, P = 1.7 × 10−18). In addition to KIF1B, the association region tagged two other plausible causative genes, UBE4B and PGD. Our findings provide evidence that the 1p36.22 locus confers susceptibility to HBV-related HCC, and suggest that KIF1B-, UBE4B- or PGD-related pathways might be involved in the pathogenesis of this malignancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regional plots for associations at 1p36.22.

Similar content being viewed by others

References

  1. Bosch, F.X., Ribes, J., Cleries, R. & Diaz, M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9, 191–211 (2005).

    Article  Google Scholar 

  2. Chen, C.J., Yu, M.W. & Liaw, Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 12, S294–S308 (1997).

    Article  CAS  Google Scholar 

  3. McGlynn, K.A. & London, W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol. 19, 3–23 (2005).

    Article  Google Scholar 

  4. Yu, M.W. et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am. J. Epidemiol. 145, 1039–1047 (1997).

    Article  CAS  Google Scholar 

  5. Chen, C.J. & Chen, D.S. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36, 1046–1049 (2002).

    Article  Google Scholar 

  6. Kim, Y.J. & Lee, H.S. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 48, 10–15 (2005).

    Article  CAS  Google Scholar 

  7. Zhai, Y. et al. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 130, 2001–2009 (2006).

    Article  CAS  Google Scholar 

  8. Aulchenko, Y.S. et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat. Genet. 40, 1402–1403 (2008).

    Article  CAS  Google Scholar 

  9. Stacey, S.N. et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat. Genet. 40, 1313–1318 (2008).

    Article  CAS  Google Scholar 

  10. Bagchi, A. & Mills, A.A. The quest for the 1p36 tumor suppressor. Cancer Res. 68, 2551–2556 (2008).

    Article  CAS  Google Scholar 

  11. Li, S.P. et al. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J. Hepatol. 34, 840–849 (2001).

    Article  CAS  Google Scholar 

  12. Midorikawa, Y. et al. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 49, 513–522 (2009).

    Article  CAS  Google Scholar 

  13. Nangaku, M. et al. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79, 1209–1220 (1994).

    Article  CAS  Google Scholar 

  14. Yeh, I.T. et al. A germline mutation of the KIF1B βgene on 1p36 in a family with neural and nonneural tumors. Hum. Genet. 124, 279–285 (2008).

    Article  CAS  Google Scholar 

  15. Yang, H.W. et al. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Oncogene 20, 5075–5083 (2001).

    Article  CAS  Google Scholar 

  16. Benn, D.E. et al. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Res. 60, 7048–7051 (2000).

    CAS  PubMed  Google Scholar 

  17. Schlisio, S. et al. The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22, 884–893 (2008).

    Article  CAS  Google Scholar 

  18. Munirajan, A.K. et al. KIF1Bβ functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J. Biol. Chem. 283, 24426–24434 (2008).

    Article  CAS  Google Scholar 

  19. Hoeller, D., Hecker, C.M. & Dikic, I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6, 776–788 (2006).

    Article  CAS  Google Scholar 

  20. Dawson, S.P. Hepatocellular carcinoma and the ubiquitin-proteasome system. Biochim. Biophys. Acta 1782, 775–784 (2008).

    Article  CAS  Google Scholar 

  21. Koegl, M. et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635–644 (1999).

    Article  CAS  Google Scholar 

  22. Krona, C. et al. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22, 2343–2351 (2003).

    Article  CAS  Google Scholar 

  23. Chatterjee, A. et al. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of Np63α. Cell Cycle 7, 1231–1237 (2008).

    Article  CAS  Google Scholar 

  24. Novello, F. & McLean, P. The pentose phosphate pathway of glucose metabolism. Measurement of the non-oxidative reactions of the cycle. Biochem. J. 107, 775–791 (1968).

    Article  CAS  Google Scholar 

  25. Turyn, J. et al. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm. Metab. Res. 35, 565–569 (2003).

    Article  CAS  Google Scholar 

  26. Giusti, L. et al. Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J. Proteome Res. 7, 4079–4088 (2008).

    Article  CAS  Google Scholar 

  27. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

  28. Kazeem, G.R. & Farrall, M. Integrating case-control and TDT studies. Ann. Hum. Genet. 69, 329–335 (2005).

    Article  CAS  Google Scholar 

  29. Nicodemus, K.K. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 9, 130 (2008).

    Article  Google Scholar 

  30. Browning, B.L. & Browning, S.R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84, 210–223 (2009).

    Article  CAS  Google Scholar 

  31. Sole, X., Guino, E., Valls, J., Iniesta, R. & Moreno, V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22, 1928–1929 (2006).

    Article  CAS  Google Scholar 

  32. Menashe, I., Rosenberg, P.S. & Chen, B.E. PGA: power calculator for case-control genetic association analyses. BMC Genet. 9, 36 (2008).

    Article  Google Scholar 

  33. Yu, M.W. et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J. Natl. Cancer Inst. 92, 1159–1164 (2000).

    Article  CAS  Google Scholar 

  34. Houlston, R.S. & Ford, D. Genetics of coeliac disease. QJM 89, 737–743 (1996).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the subjects and their families for participating in this study, and the clinicians, nurses and study coordinators for their contributions. This study was supported in part by grants from Chinese National High-tech Program 2006AA02A412 (G.Z.), Chinese Key Project for Infectious Diseases 2008ZX10002-016 (G.Z.), Chinese National Science Fund for Creative Research Groups Program 30621063 (F.H.) and Beijing Science and Technology NOVA program 2006A54 (G.Z.).

Author information

Authors and Affiliations

Authors

Contributions

G.Z. and F.H. were the overall GWAS study principal investigators who conceived the study and obtained financial support. F.H., G.Z. and H.Z. designed the study. Y.C., W.X., R.L., Z.W., F.M. and W.H. were responsible for recruitment of Guangxi subjects, phenotype collection and biological sample collection and preparation. W.J., Y.Y., M.C. and Y.-X.Z. were responsible for recruitment of Guangdong subjects, phenotype collection and biological sample collection and preparation. Z.H., H.S. and X.Y. were responsible for recruitment of Jiangsu subjects, phenotype collection and biological sample collection and preparation. J.Y. and J.Q. were responsible for recruitment of Shanghai subjects, phenotype collection and biological sample collection and preparation. C.W. and D.L. were responsible for recruitment of Beijing subjects, phenotype collection and biological sample collection and preparation. Y.Z., L.Y., P.L., Z.W., F.M., W.H., W.Y., M.C., X.Z., W.Q., H.Y. and H.Z. performed genotyping in the replication stage. X.X. helped to manage genotype data. F.G., Y.Z. and F.M. conducted functional experiments. G.Z. and H.Z. conducted sample selection and data management, performed statistical analyses, interpreted results and wrote the manuscript.

Corresponding authors

Correspondence to Fuchu He or Gangqiao Zhou.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1–15, Supplementary Figures 1–10 and Supplementary Note (PDF 1672 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, H., Zhai, Y., Hu, Z. et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42, 755–758 (2010). https://doi.org/10.1038/ng.638

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.638

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing